Bergey J L, Much D R
Eur J Pharmacol. 1986 Aug 22;128(1-2):109-18. doi: 10.1016/0014-2999(86)90564-9.
The Ca2+ entry blockers diltiazem, nifedipine and verapamil produced dose-dependent increases in atrioventricular conduction time (A-H interval), while decreasing heart rate and mean arterial pressure in anesthetized dogs previously subjected to ganglionic blockade to prevent hypotension-induced reflex changes in sympathetic tone. Nifedipine and verapamil, but not diltiazem, also reduced (P less than 0.05) the tachycardia produced by electrical stimulation of the cardioaccelerator nerve at doses which did not alter the heart rate response to direct beta-adrenoceptor stimulation by isoproterenol (0.1 microgram/kg i.v.). The lowest doses of nifedipine (0.03 mg/kg) and verapamil (0.3 mg/kg) that produced decreases in mean arterial blood pressure were the same as or greater than those which selectivity reduced the tachycardiac effects of low frequency (1 Hz, 25-35 V, 5 ms), but not high frequency (10 Hz, 25-35 V, 5 ms) cardiac nerve stimulation. These data suggest that threshold vasodilator doses of some Ca2+ blockers may selectively reduce low level (or basal) sympathetic neurotransmission and this additional pharmacologic action may contribute to the antihypertensive mechanism. The failure to inhibit the high frequency nerve response may also help to explain the relatively low incidence of orthostatic hypotension associated with the clinical use of Ca2+ blockers as compared to other direct-acting vasodilators.
钙通道阻滞剂地尔硫䓬、硝苯地平和维拉帕米可使麻醉犬的房室传导时间(A-H间期)呈剂量依赖性增加,同时降低心率和平均动脉压,这些犬事先已接受神经节阻断以防止低血压引起的交感神经张力反射性变化。硝苯地平和维拉帕米,但不是地尔硫䓬,在不改变异丙肾上腺素(0.1微克/千克静脉注射)对直接β-肾上腺素能受体刺激的心率反应的剂量下,也降低了(P<0.05)电刺激心脏加速神经所产生的心动过速。硝苯地平(0.03毫克/千克)和维拉帕米(0.3毫克/千克)产生平均动脉血压下降的最低剂量与选择性降低低频(1赫兹,25-35伏,5毫秒)但不降低高频(10赫兹,25-35伏,5毫秒)心脏神经刺激的心动过速效应的剂量相同或更高。这些数据表明,某些钙通道阻滞剂的阈剂量血管扩张剂可能选择性地降低低水平(或基础)交感神经传递,这种额外的药理作用可能有助于抗高血压机制。未能抑制高频神经反应也可能有助于解释与其他直接作用血管扩张剂相比,钙通道阻滞剂临床使用时体位性低血压发生率相对较低的原因。